2005
DOI: 10.1002/chem.200500901
|View full text |Cite
|
Sign up to set email alerts
|

Non‐Covalent Polyvalent Ligands by Self‐Assembly of Small Glycodendrimers: A Novel Concept for the Inhibition of Polyvalent Carbohydrate–Protein Interactions In Vitro and In Vivo

Abstract: Polyvalent carbohydrate-protein interactions occur frequently in biology, particularly in recognition events on cellular membranes. Collectively, they can be much stronger than corresponding monovalent interactions, rendering it difficult to control them with individual small molecules. Artificial macromolecules have been used as polyvalent ligands to inhibit polyvalent processes; however, both reproducible synthesis and appropriate characterization of such complex entities is demanding. Herein, we present an … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
34
0

Year Published

2006
2006
2012
2012

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 36 publications
(34 citation statements)
references
References 48 publications
0
34
0
Order By: Relevance
“…Glycoclusters [10] have been obtained by appending saccharide residues to b-cyclodextrin [11] and calixarene cores. [10] Other approaches have involved, for example, combinatorial glycosamino acids [12] and oligosaccharide [13] derivatives, dynamic monolayers, [14] a polyrotaxane, [15] self-assembling glycodendrimers, [16] and conjugating carbohydrate residues to a polymerizable scaffold, to prepare glycopolymers. [17] Extending our work on dynamers [4, 5a, 6, 7] to the biopolymer area, [8b] we were interested in designing a dynamic analogue of such glycopolymers (glycodynamers) that could confer an adaptive character which would enable them to modify their constitution in response to external physical or chemical stimuli (temperature, pH, etc.)…”
mentioning
confidence: 99%
“…Glycoclusters [10] have been obtained by appending saccharide residues to b-cyclodextrin [11] and calixarene cores. [10] Other approaches have involved, for example, combinatorial glycosamino acids [12] and oligosaccharide [13] derivatives, dynamic monolayers, [14] a polyrotaxane, [15] self-assembling glycodendrimers, [16] and conjugating carbohydrate residues to a polymerizable scaffold, to prepare glycopolymers. [17] Extending our work on dynamers [4, 5a, 6, 7] to the biopolymer area, [8b] we were interested in designing a dynamic analogue of such glycopolymers (glycodynamers) that could confer an adaptive character which would enable them to modify their constitution in response to external physical or chemical stimuli (temperature, pH, etc.)…”
mentioning
confidence: 99%
“…
The design of polyvalent molecules [1][2][3][4][5], consisting of multiple copies of a ligand attached to a suitable scaffold, represents a promising approach for designing potent inhibitors of pathogens and microbial toxins [1,[6][7][8][9][10][11]. Liposomes are particularly attractive scaffolds for designing polyvalent inhibitors [9,10,[12][13][14][15]; however, the poor colloidal stability of conventional liposomes and their short circulation times in vivo [16,17] are major obstacles limiting their therapeutic use.
…”
mentioning
confidence: 99%
“…Then, the buffer solution was replaced by the b-PAH solution which was acting as a multivalent ligand [42,43] bioconjugating the Fc-SAv layer. In contrast to the first FcSAv layer, the recognition-mediated assembly of b-PAH displayed a slower decrease in frequency reaching a plateau after 50 min.…”
Section: Resultsmentioning
confidence: 99%